SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  LEAD PLAINTIFF DEADLINE: The Alexander Firm P.C. Announces Upcoming Lead Plaintiff Deadline of March 17, 2014, Concerning Class Actions Against Aegerion Pharmaceuticals, Inc.

[March 06, 2014]

LEAD PLAINTIFF DEADLINE: The Alexander Firm P.C. Announces Upcoming Lead Plaintiff Deadline of March 17, 2014, Concerning Class Actions Against Aegerion Pharmaceuticals, Inc.

LOS ANGELES --(Business Wire)--

The Alexander Firm P.C., A Professional Law Corporation, reminds investors who purchased or acquired shares of Aegerion Pharmaceuticals, Inc. ("Aegerion" or the "Company") (NASDAQ: AEGR) between March 15, 2012 and January 9, 2014 (the "Class Period") that the deadline of March 17, 2014, is quickly approaching to move for Lead Plaintiff in the securities class actions filed on behalf of investors against the Company and certain of its officers.

Aegerion markets its cholesterol drug Juxtapid in the United States. Juxtapid is the sole FDA-approved Aegerion product and was approved by U.S. health regulators in December 2012 to treat patients with homozygous familial hypercholesterolemia (HoFH), a rare genetic disease that impairs the function of the receptor responsible for removing LDL-C or "bad" cholesterol from the blood. The actions allege that Aegerion's marketng practices during the Class Period were in violation of the Food, Drug, and Cosmetic Act (FDCA), and that defendants made false and misleading statements or failed to disclose to Aegerion investors that: (a) the Company marketed its drugs in violation of the FDCA; and (b) as a result, the Company faced heightened regulatory scrutiny by the FDA and other governmental bodies.


On January 10, 2014, the Company received a subpoena from the U.S. Department of Justice requesting documents regarding its marketing and sale of Juxtapid. As a result of this news, Aegerion shares declined $7.98 per share, or nearly 11%, to close at $65.77 per share on January 10, 2013.

If you purchased or acquired Aegerion common stock between March 15, 2012 and January 9, 2014, you have until March 17, 2014, to move the Court to be appointed Lead Plaintiff. If you believe you have suffered losses in excess of $100,000, would like to learn more about these claims, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Vahn Alexander, Esq., The Alexander Firm P.C., A Professional Law Corporation, 1875 Century Park East, Suite 700, Los Angeles, California 90067, by telephone at (310) 407-5335, or by email to info@alexanderfirmpc.com, or visit our website at www.alexanderfirmpc.com. With 20 years of class action and complex litigation experience, The Alexander Firm is committed to protecting the rights of investors throughout the Country. This press release may be considered Attorney Advertising in some jurisdictions.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy